SIVEXTRO is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Tedizolid Phosphate.
Product ID | 67919-041_10489cbd-c2b3-48f1-aece-a39fc0f959c8 |
NDC | 67919-041 |
Product Type | Human Prescription Drug |
Proprietary Name | SIVEXTRO |
Generic Name | Tedizolid Phosphate |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2014-06-20 |
Marketing Category | NDA / NDA |
Application Number | NDA205435 |
Labeler Name | Merck Sharp & Dohme Corp. |
Substance Name | TEDIZOLID PHOSPHATE |
Active Ingredient Strength | 200 mg/1 |
Pharm Classes | Oxazolidinone Antibacterial [EPC],Oxazolidinones [CS],Breast Cancer Resistance Protein Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2014-06-20 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA205435 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2014-06-20 |
Marketing Category | NDA |
Application Number | NDA205435 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2014-06-20 |
Ingredient | Strength |
---|---|
TEDIZOLID PHOSPHATE | 200 mg/1 |
SPL SET ID: | 75672079-589f-451a-bdbf-eaebcfcc80a9 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
67919-040 | SIVEXTRO | tedizolid phosphate |
67919-041 | SIVEXTRO | tedizolid phosphate |
72000-310 | SIVEXTRO | tedizolid phosphate |
72000-320 | SIVEXTRO | tedizolid phosphate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
SIVEXTRO 85750866 4597817 Live/Registered |
MERCK SHARP & DOHME CORP. 2012-10-10 |